Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Pretreatment with GLP-1(2836) increases glycolysis and glucose oxidation, and decreases FAO in coronary vascular cells
2002, 18(9): 782-783
GHK-Cu Copper Peptide 300 mcg
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed for type 2 diabetes treatment in the UK, administered subcutaneously once weekly
Retatrutide (LY3437943) is an investigational triple agonist targeting GIP, GLP-1, and glucagon receptors, currently under clinical evaluation for obesity and metabolic disease
US$ 21.22
US$ 21.12
US$ 27.17
US$ 29.83
US$ 26.41
US$ 29.65
US$ 23.04
US$ 28.75
US$ 23.04
